Markel Group (MKL) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
29 Apr, 2026Executive summary
Adjusted operating income rose 4% year-over-year to $498 million, driven by improved insurance underwriting and disciplined capital allocation, despite a 21% drop in gross written premiums due to strategic exits and business model changes.
Markel Insurance segment adjusted operating income increased 31% to $369 million, with a combined ratio improvement to 93% from 96% year-over-year.
Net loss to shareholders was $212.3 million for Q1 2026, compared to net income of $121.7 million in Q1 2025, driven by significant unrealized investment losses and catastrophe claims.
Share repurchases continued, totaling $134 million in Q1 2026, reducing share count by 10% over five years.
Significant events included losses from the Middle East conflict and the transition of the Hagerty business to a fronting arrangement.
Financial highlights
Operating revenues were $3.55 billion, flat year-over-year.
Operating loss was $273 million, mainly due to $728 million in net investment losses from unrealized equity declines.
Operating cash flow dropped to $16 million from $376 million, impacted by reinsurance payments and runoff of Global Re.
Comprehensive loss to shareholders was $340 million, compared to income of $348 million in Q1 2025.
Net income per diluted share was $(18.90), down from $12.08 in Q1 2025.
Outlook and guidance
Management expects continued volatility in investment results due to market conditions and ongoing geopolitical risks.
Insurance operations expected to grow and earn healthy returns on equity over the next five years.
International insurance growth expected to moderate to low-to-mid teens for the remainder of the year after a 28% surge in Q1.
Management anticipates continued double-digit returns on capital, with earnings and cash flows divided by fewer shares.
Additional losses from the Middle East conflict may be incurred in future periods, potentially impacting results.
Latest events from Markel Group
- Operating income rose to $3.2B, with broad-based growth and improved insurance profitability.MKL
Q4 202511 Apr 2026 - Board backs charter amendment, opposes climate and special meeting proposals, and details pay.MKL
Proxy filing2 Apr 2026 - Key votes include director elections, auditor ratification, and proposals on ESG and shareholder rights.MKL
Proxy filing2 Apr 2026 - Board recommends all management proposals and opposes both shareholder proposals at the 2026 meeting.MKL
Proxy Filing6 Mar 2026 - H1 2024 revenues up 5%, but Q2 income fell on equity volatility and discontinued product losses.MKL
Q2 20242 Feb 2026 - Net income and operating income surged, with robust investment gains and ongoing share repurchases.MKL
Q3 202417 Jan 2026 - Operating income jumped 27% to $3.71B, with improved insurance and major share repurchases.MKL
Q4 20248 Jan 2026 - Key votes include director elections, auditor ratification, and ESG-related shareholder proposals.MKL
Proxy Filing1 Dec 2025 - Board recommends director slate, performance-based pay, and opposes GHG and voting proposals.MKL
Proxy Filing1 Dec 2025